Bank of New York Mellon »

Elevation Oncology shares owned by Bank of New York Mellon

Quarter-by-quarter ownership of Elevation Oncology (ELEV) shares owned by Bank of New York Mellon from 13F filings

Historical chart of Bank of New York Mellon investment in Elevation Oncology

Tip: Access up to 7 years of quarterly data

All positions including Elevation Oncology held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Elevation Oncology by Bank of New York Mellon

Quarter filed Position value Share count Share price at filing
2024-09-30 $74k 124k 0.60
2024-06-30 $415k 154k 2.70

More positions owned by Bank of New York Mellon

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Inc-class A Cl A (META)
Ishares Core S&p 500 Etf Core (IVV)
Alphabet Cap (GOOGL)
Alphabet Inc-cl C Cap (GOOG)
Broadcom (AVGO)
Berkshire Hathaway Inc-cl B CL B (BRK.B)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Mastercard Inc - A Cl A (MA)
UnitedHealth (UNH)
Exxon Mobil Corporation (XOM)

View all positions for Bank of New York Mellon

Top funds holding Elevation Oncology

Frazier Life Sciences Management
Tang Capital Management
Logos Global Management
Farallon Capital Management
BVF
BlackRock
Aisling Capital Management
BlackRock
Balyasny Asset Management
Vanguard Group
Renaissance Technologies
Hudson Bay Capital Management
Palo Alto Investors
Morgan Stanley
Geode Capital Management

View all funds holding Elevation Oncology